Company: BDRX
Filing Date: 2025-05-02
Form Type: 6-K
Source: 0001214659-25-006889
Chunk: 0

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-02
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________

FORM 6-K

___________________________

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

For the month of May 2025

Commission File Number 001-37652

Biodexa Pharmaceuticals PLC

(Translation of registrant’s name into English)

1 Caspian Point,

Caspian Way

Cardiff, CF10 4DQ, United Kingdom

(Address of principal executive offices)</div>

Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:

Form 20-F x Form
40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

Results of General Meeting

On May 2, 2025, Biodexa Pharmaceuticals PLC (the “Company”)
announced that at its General Meeting held on such date, ordinary resolutions 1 and 2 were passed by majorities of 62% and 61%, respectively.
Special resolution 3 failed to pass with a majority vote of 71%. Because resolution 1 was contingent on the passing of resolution 3, resolution
1 also failed to pass.

The information included under the heading “Results of General Meeting” shall be deemed to be incorporated by reference into the registration statements on Form S-8 (Registration Number 333-209365) and Form F-3 (Registration Number 333-267932) of the Company (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

Press Release

On May 2, 2025, the Company issued a press release regarding the results
of the General Meeting, a copy of which is attached to this Form 6-K as Exhibit 99.1.

The information in the attached Exhibit 99.1 is being furnished and shall not